Patent ID: 11872250
Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 2:
3. A method for inducing an immune response in a patient in need thereof comprising administering to said patient a composition comprising an effective amount of a population of isolated trained mesenchymal stem cells activated by exposure to IFNγ and an effective amount of at least one cytokine for inducing an immune response, the at least one cytokine selected from the group consisting of IL-1 α, IL-1 β, TNF α, IFN-I α, IFN-I β, TGF β, and FGF for sufficient amount of time for a sufficient period of time such that the activated mesenchymal stem cells are immunomodulatory.